Advertisement
From 1997 through 2016

Medical Marketing Has Increased in Past 20 Years

0
Considerable increase seen from 1997 through 2016, especially in direct-to-consumer advertising
The costs of having two noncommunicable diseases is generally superadditive

Costs Higher for Those With Comorbid Noncommunicable Diseases

0
Health expenditure greater for person with two diseases simultaneously than for the diseases separately
The overall cancer death rate decreased continuously by 27 percent from 1991 to 2016

Cancer Death Rate in U.S. Decreased Continuously From 1991 to 2016

0
Socioeconomic inequalities are widening, but racial gap in cancer mortality narrowing slowly
Survivors of childhood Hodgkin lymphoma remain at increased risk for developing subsequent malignant neoplasms

Childhood Hodgkin Lymphoma Survivors at Risk for Later Cancers

0
Survivors have 14-fold increased risk for developing a solid subsequent malignant neoplasm
Patients with a cancer diagnosis have an increased risk for suicide during the first year after their diagnosis compared with the general population

Risk for Suicide Increased in Year After Cancer Diagnosis

0
Higher suicide rates observed for cancers with poor prognosis, including pancreatic, lung cancer
Screening donated blood for Zika virus is cost-effective only in the high mosquito season in Puerto Rico

Screening Donated Blood for Zika Not Cost-Effective

0
Universal mini-pool nucleic acid testing only during high mosquito activity cost-effective in Puerto Rico
The risks for therapy-related myelodysplastic syndrome or acute myeloid leukemia are elevated after chemotherapy use for solid tumors

Myelodysplastic Syndrome/AML Risk Increased After Chemo

0
Since 2000, risks for therapy-related myelodysplastic syndrome, AML up after chemo for solid cancers
A psychoeducational intervention does not improve anxiety or body image but is still considered important among women with breast cancer

Psychoeducational Intervention of Little Benefit in Breast Cancer

0
However, patients said that psychoeducational group study was important intervention for their life
Sex differences have been identified in response to therapy among glioblastoma patients

Sex Differences ID’d in Response to Glioblastoma Treatment

0
Standard therapy more effective for female versus male patients with glioblastoma
There is no compelling evidence to indicate health benefits of nonsugar sweetener use on a range of health outcomes

Health Benefits of Nonsugar Sweeteners Uncertain

0
However, large systematic review could not rule out harms from nonsugar sweeteners